text
"[""\n1. 요약재무정보\n가. 요약연결재무정보\n\xa0 \xa0 \xa0 ( 단위 : 천원 )\n구분\n제 51 기 분기\n제 50 기\n제 49\xa0 기\n연결재무상태표\n2021. 09월말\n2020. 12월말\n2019. 12월말\n\xa0[유동자산]\n19,648,799\n20,426,044\n156,392,087\n\xa0ㆍ현금및현금성자산\n5,066,870\n2,421,594\n19,127,037\n\xa0ㆍ단기금융상품\n50,000\n-\n506,746\n\xa0ㆍ매출채권\n10,012,431\n14,487,472\n39,224,535\n\xa0ㆍ기타자산\n2,083,360\n3,277,070\n60,226,286\n\xa0ㆍ매각예정비유동자산\n-\n-\n27,000,000\n\xa0ㆍ재고자산\n2,436,138\n239,908\n10,307,483\n\xa0[비유동자산]\n76,681,290\n48,170,596\n217,480,637\n\xa0ㆍ금융자산\n2,912,757\n2,466,679\n5,408,834\n\xa0ㆍ종속기업및관계기업투자\n44,052,711\n42,868,381\n1,332,670\n\xa0ㆍ유형자산\n13,881,065\n71,965\n194,477,649\n\xa0ㆍ사용권자산\n2,319,666\n908,620\n1,965,985\n\xa0ㆍ무형자산\n10,631,634\n726,936\n6,141,470\n\xa0ㆍ장기매출채권\n218,609\n218,609\n550,000\n\xa0ㆍ기타자산\n2,664,848\n909,406\n7,604,029\n자\xa0 산\xa0 총\xa0 계\n96,330,089\n68,596,640\n373,872,724\n\xa0[유동부채]\n30,669,321\n45,070,943\n146,131,910\n\xa0[비유동부채]\n23,312,121\n3,851,122\n72,429,838\n부 채 총 계\n53,981,442\n48,922,065\n218,561,748\n\xa0[지배기업 소유지지분]\n28,928,159\n19,674,575\n24,871,939\n\xa0ㆍ자본금\n14,415,293\n12,508,293\n12,508,293\n\xa0ㆍ자본잉여금\n47,835,783\n35,270,580\n35,081,035\n\xa0ㆍ기타자본항목\n1,428,920\n1,428,920\n1,535,326\n\xa0ㆍ기타포괄손익누계액\n(3,051,156)\n(1,635,666)\n17,510,367\n\xa0ㆍ이익잉여금\n(31,700,681)\n(27,897,552)\n(41,763,082)\n\xa0[비지배지분]\n13,420,488\n-\n130,439,037\n자 본 총 계\n42,348,647\n19,674,575\n155,310,976\n연결손익계산서\n'21.01.01~09.30\n'20.01.01~12.31\n'19.01.01~12.31\n\xa0매출액\n41,958,736\n72,469,645\n58,736,694\n\xa0영업손익\n(4,467,028)\n(1,999,554)\n1,013,792\n\xa0연결계속영업당기순이익\n(1,834,013)\n(10,311,445)\n(9,772,257)\nㆍ지배기업소유주지분손익\n(1,834,013)\n(10,311,445)\n(9,772,257)\n\xa0연결중단영업당기순이익\n-\n9,184,574\n5,395,995\n\xa0당기순손익\n(1,834,013)\n(1,126,871)\n(4,376,262)\n\xa0주당순손익(원)\n(65)\n(412)\n(391)\n\xa0연결에포함된회사수\n1개\n-\n4개\n※ 상기 요약 재무정보는 한국 채택국제회계기준(K-IFRS)에 따라 작성되었습니다.※ 2019년 1월 1일을 최초적용일로 하여 K-IFRS 제1116호를 최초 적용하였습니다.\n나. 연결재무제표의 연결에 포함된 회사\n종속기업명\n소유지분율\n소재지\n결산월\n업종\n셀론텍(주)\n51.0%\n한국\n12월\n바이오콜라겐 기반 치료재료 생산 및 판매\n다. 요약재무정보(별도)\n\xa0 \xa0 \xa0 ( 단위 : 천원 )\n구분\n제 51 기 분기\n제 50 기\n제 49\xa0 기\n재무상태표\n2021. 09월말\n2020. 12월말\n2019. 12월말\n\xa0[유동자산]\n14,667,087\n20,426,044\n156,392,087\n\xa0ㆍ현금및현금성자산\n616,215\n2,421,594\n19,127,037\n\xa0ㆍ단기금융상품\n-\n-\n506,746\n\xa0ㆍ매출채권\n12,036,487\n14,487,472\n39,224,535\n\xa0ㆍ기타자산\n1,757,395\n3,277,070\n60,226,286\n\xa0ㆍ매각예정비유동자산\n-\n-\n27,000,000\n\xa0ㆍ재고자산\n256,990\n239,908\n10,307,483\n\xa0[비유동자산]\n70,800,689\n48,170,596\n217,480,637\n\xa0ㆍ금융자산\n2,403,922\n2,466,679\n5,408,834\n\xa0ㆍ종속기업및관계기업투자\n60,809,073\n42,868,381\n1,332,670\n\xa0ㆍ유형자산\n61,088\n71,965\n194,477,649\n\xa0ㆍ사용권자산\n455,807\n908,620\n1,965,985\n\xa0ㆍ무형자산\n5,856,399\n726,936\n6,141,470\n\xa0ㆍ장기매출채권\n218,609\n218,609\n550,000\n\xa0ㆍ기타자산\n995,791\n909,406\n7,604,029\n자\xa0 산\xa0 총\xa0 계\n85,467,776\n68,596,640\n373,872,724\n\xa0[유동부채]\n36,420,511\n45,070,943\n146,131,910\n\xa0[비유동부채]\n18,874,453\n3,851,122\n72,429,838\n부 채 총 계\n55,294,964\n48,922,065\n218,561,748\n\xa0[지배기업 소유지지분]\n30,172,812\n19,674,575\n24,871,939\n\xa0ㆍ자본금\n14,415,293\n12,508,293\n12,508,293\n\xa0ㆍ자본잉여금\n47,483,854\n35,270,580\n35,081,035\n\xa0ㆍ기타자본항목\n1,428,920\n1,428,920\n1,535,326\n\xa0ㆍ기타포괄손익누계액\n(3,052,212)\n(1,635,666)\n17,510,367\n\xa0ㆍ이익잉여금\n(30,103,043)\n(27,897,552)\n(41,763,082)\n\xa0[비지배지분]\n-\n-\n130,439,037\n자 본 총 계\n30,172,812\n19,674,575\n155,310,976\n종속기업및관계기업 투자주식의 평가방법\n지분법 및 원가법\n지분법\n원가법\n손익계산서\n'21.01.01~09.30\n'20.01.01~12.31\n'19.01.01~12.31\n\xa0매출액\n41,958,736\n72,469,645\n58,736,694\n\xa0영업손익\n(4,467,028)\n(1,999,554)\n1,013,792\n\xa0계속영업당기순이익\n(2,212,595)\n(10,311,445)\n(9,772,257)\n\xa0중단영업당기순이익\n-\n9,184,574\n5,395,995\n\xa0당기순손익\n(2,212,595)\n(1,126,871)\n(4,376,262)\n\xa0주당순손익(원)\n(78)\n(412)\n(391)\n※ 상기 요약 재무정보는 한국 채택국제회계기준(K-IFRS)에 따라 작성되었습니다.※ 2019년 1월 1일을 최초적용일로 하여 K-IFRS 제1116호를 최초 적용하였습니다.\r\n""]"
